-Reuters
Theravance Biopharma Q2 EPS $(0.04) Up From $(0.80) YoY, Sales $11.05M Miss $12.41M Estimate
Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.04) per share. This is a 95 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of